期刊文献+

大鼠急性放射性肝损伤及其保护的实验研究 被引量:3

Study on Mechanisms of Radiation-induced Hepatic Injury and Its Protection
下载PDF
导出
摘要 目的:探讨活性氧自由基(ROS)、一氧化氮(NO)和TGF-β1在大鼠急性放射性肝损伤中的机制及细胞保护剂安福定对大鼠急性放射性肝损伤的保护作用。方法:健康雄性SD大鼠48只,随机分成正常对照组(C组)、安福定组(A组)、单纯照射组(X组)3组各16例。正常对照组不予照射。其余两组给予一次性全肝照射,照射剂量20Gy。安福定组于照射前30 min腹腔内注射安福定200mg/kg;单纯照射组则照射前腹腔注射等容量的生理盐水。结果:照射后第4、8、14天的血ALT、AST、肝组织光镜未出现明显变化。电镜下明显的超微结构改变。单纯放射组大鼠血浆ROS活性明显高于正常对照组(P<0.05)。安福定组血浆MDA含量显著低于正常对照组,而SOD活性则高于正常对照组。单纯放射组大鼠血浆NO含量明显高于正常对照组和安福定组P<0.05)。照射后第14天单纯放射组大鼠血浆TGF-β1含量明显高于正常对照组和安福定组(P<0.05)。结论:ROS、NO和TGF-β1都参与了急性放射性肝损伤。NO和TGF-β1则分别作为炎症介质和炎性细胞因子在损伤的进程中起关键作用。安福定对放射性肝损伤有保护作用。测定血MDA含量及SOD活性、NO和TGF-β1比血AL、AST更早提示放射性肝损伤。 Objective: To observe the effects of oxygen free radical(ROS) ,nitric oxide(NO) and TGF-β1 on the acute radiation-induced hepatic injury of rats. The protective effect of amifostine against radiation was also discussed. Methods: Forty-eight SD rats were divided into normal group, radiated group, and amifostine-pretreated group. The models were made by a single radiation of 20Gy on whole liver except the normal group. Amifostine was given intraperitoneally (200mg/kg) 30 minutes before irradiation to amifostine group. The levels of plasma ROS,NO, TGF-β1 in rats were measured on the 4th,8th and 14th day after radiation. Animals were euthanized 14 days after irradiation, and the hepatic tissues were observed under microscope and electronficroscope. The plasma concentrations of AST,ALT of rats were also measured. Results: The hepatic cells showed no difference among three group under the mi- croscope, but some changes were observed by the transmission electromicroseope. No significant difference of AST,ALT were observed among three groups. The concentrations of ROS significantly increased in radiated group (P 〈 0. 05 ). In group Amifostine ,the activity of SOD increased while the level of MDA decreased compared with the normal group( P 〈 0. 05). The concentrations of NO were significantly higher in radiated group( P 〈 0. 05 ). On the 14th day after radiation the concentrations of TGF-β1 increased significantly in radiated group (P 〈0. 05). Conclusion: ROS,NO and TGF-β1 play an important part in the acute radiation-induced hepatic injury of rats. Amifostine has a marked protective effect to hepatic injury. The plasma concentration changes of ROS,NO,TGF-β1 are much earlier than AST,ALT of rats with radiation-induced hepatic injury.
出处 《肿瘤预防与治疗》 2011年第1期9-13,共5页 Journal of Cancer Control And Treatment
关键词 放射性肝损伤 活性氧自由基 一氧化氮 TGF-Β1 安福定 Radiation-lnduced Hepatic Injury Oxygen Free Radical(ROS) Nitric Oxide(NO) TGF-β1 Amifostine
  • 相关文献

参考文献15

  • 1Liang SX,Zhu XD,Xu ZY,et al.Radiation-induced liver disease in three-dimensional conformal radiation therapy for primm7 liver carcinonla:the risk factors and hepatic radiation tolerance[J].Int J Radiat Oncol Biol Phys,2006,65(2):426-434.
  • 2Ghafoori P,Marks LB,Vujaskovie Z,et al.Radiation-induced lung injury.Assessment,management,and prevention[J].Oncology,2008,22(1):37-47.
  • 3夏红强,金冶宁.Amifostine在恶性肿瘤放疗中的应用[J].现代肿瘤医学,2009,17(4):774-776. 被引量:5
  • 4Koc M,Taysi S,Buyukokuroglu ME,et al.Melatonin protects rat liver against irradiation-induced oxidative injury[J].J Radiat Res (Tokyo),2003,44(3):211-215.
  • 5Abou-Seif MA,El-Naggar MM,El-Far M,et al.Amelioration of radiation-induced oxidative stress and biochemical alteration by SOD model compounds in pre-treated gamma-irradiated rats[J].Clin Chim Acta,2003,337(1-2):23-33.
  • 6Manzanas García A,L ápez Carrizosa MC,Vallejo Oea (n) a C,et al.Superoxidase disnmtase (SOD) topical use in oneologie patients:treatment of acute cutaneous toxicity secondary to radiotherapy[J].Clin Transl Oncol,2008,10(3):163-167.
  • 7Ohta S,Matsuda S,Gunji M,et al.The role of nitric oxide in radiation damage[J].Biol Pharm Bull,2007,30(6):1102-1107.
  • 8Giaid A,Lehnert SM,Chehayeb B,et al.Inducible nitric oxide synthase and nitrotyrosine in mice with radiation-induced lung damage[J].Am J Clin Oncol,2003,26(4):67-72.
  • 9Erbil Y,Dibekoglu C,Turkoglu U,et al.Nitric oxide and radiation enteritis[J].Eur J Surg,1998,164(11):863-868.
  • 10Taysi S,Koc M,Büyükokuroglu ME,et al.Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver[J].J Pineal Res,2003,34(3):173-177.

二级参考文献17

  • 1Hu K,Ship JA ,Harrison LB. Rationale for integrating high -dose rate intraoperative radiation ( HDR - fORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage Ⅲ/Ⅳ head and neck cancer[ J]. Semin Oncol, 2003,30(6 Suppl 18) :40 -48.
  • 2Amrein PC, Clark JR, Supko JG. Phase Ⅰ trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma [ J ]. Cancer, 2005, 104 ( 7 ) : 1418 - 1427.
  • 3Wasserman TH, Brizel DM, Henke M. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head - and - neck cancer:2 - year follow - up of a prospective, randomized, phase Ⅲ trial [ J ]. lent J Radiat Oncol Biol Phys, 2005,63 ( 4 ) : 985 - 990.
  • 4Nieolatou - Galitis O, Sotiropoulou - Lontou A, Velegraki A, et al. Oral eandidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection [ J ]. Oral Oncol, 2003,39 (4) :397 -401.
  • 5Bennett CL, Lane D, Stinson T, et al. Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase Ⅱ clinical trial from Germany[ J]. Cancer Invest,2001,19(2) : 107 - 113.
  • 6Koukourakis MI. Amifostine in clinical oncology : current use and future applications [ J ]. Anticancer Drugs, 2002, 13 ( 3 ) : 181 - 209.
  • 7Rades D, Fehlauer F, Bajrovic A, et al. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients [ J ]. Radiother Oncol,2004,70 ( 3 ) :261 - 264.
  • 8Kouloulias VE, Kouvaris JR, Kokakis JD, et al. Impact on cytoprotective efficacy of intermediate interval between amifostine administration and radiotherapy : a retrospective analysis [ J ]. Int J Radiat Oncol Biol Phys, 2004,59 (4) : 1148 - 1156.
  • 9Jellema AP, Slotman B J, Muller M J, et al. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly : A prospective randomized study in squamous cell head and neck cancer[ J ]. Cancer, 2006,107 (3): 544 - 553.
  • 10Ozsahin M, Betz M, Matzinger O, et al. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant - boost radiation therapy [ J ]. Arch Otolaryngol Head Neck Surg, 2006, 132 (2) :141 - 145.

共引文献4

同被引文献25

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部